Prophylaxis against acute stress erosions

Area of Science:

• Gastroenterology
• Critical Care Medicine
• Pharmacology

Background:

• Acute gastroduodenal erosions and ulcerations cause significant mortality in critically ill patients, often due to life-threatening gastrointestinal hemorrhage.
• Gastric acid hypersecretion is implicated in the development of these stress erosions.
• Current prophylactic strategies include antacids and cimetidine, a histamine H2-receptor antagonist.

Purpose of the Study:

• To review the efficacy of antacids and cimetidine in preventing bleeding from acute stress erosions in critically ill patients.
• To assess the impact of these therapies on reducing massive gastrointestinal hemorrhage and improving patient survival.
• To identify the need for further rigorous studies on stress erosion prophylaxis.

Main Methods:

• Review of existing studies on antacid and cimetidine prophylaxis for stress erosions.
• Analysis of data regarding the reduction of massive gastrointestinal hemorrhage and impact on patient survival.
• Consideration of the practicalities and regulatory status of current treatment options.

Main Results:

• Both antacids and cimetidine may be effective in preventing bleeding from stress erosions.
• However, neither therapy has demonstrated a significant decrease in massive life-threatening gastrointestinal hemorrhage.
• Importantly, treated patients have not shown increased survival rates.

Conclusions:

• Current prophylactic treatments for acute stress erosions, including antacids and cimetidine, have not demonstrably improved survival in critically ill patients.
• Cimetidine is not FDA-approved for this indication.
• Further prospective, controlled, double-blind, stratified, and randomized studies are crucial to establish the true efficacy of antacids and cimetidine in preventing stress erosion and bleeding.